×
Premier Net Cash Flow 2012-2025 | PINC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Premier net cash flow from 2012 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
View More
Premier Net Cash Flow 2012-2025 | PINC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Premier net cash flow from 2012 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$147.4B
CVS Health (CVS)
$92.8B
Elevance Health (ELV)
$71.8B
Cencora (COR)
$56.5B
DiDi Global (DIDIY)
$27.5B
Labcorp Holdings (LH)
$23.1B
Natera (NTRA)
$23.1B
BioMerieux (BMXMF)
$16.6B
EUROFINS SCIENT (ERFSF)
$14.6B
ICON (ICLR)
$14.4B
Medpace Holdings (MEDP)
$13.4B
CochLear (CHEOY)
$12.9B
Solventum (SOLV)
$12.7B
Viatris (VTRS)
$12.3B
Caris Life Sciences,�Inc (CAI)
$10.8B
Revvity (RVTY)
$10.5B
Avantor (AVTR)
$9.2B
Charles River Laboratories (CRL)
$8B
Sonic Healthcare (SKHHY)
$7.7B
HealthEquity (HQY)
$7.7B
Bausch + Lomb (BLCO)
$5.2B
Sotera Health (SHC)
$4.6B
BrightSpring Health Services (BTSG)
$4.2B
Amplifon S.p.A (AMFPF)
$3.9B
GeneDx Holdings (WGS)
$3.7B
Alignment Healthcare (ALHC)
$3.2B
Concentras Parent (CON)
$3.1B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.4B
KindlyMD (NAKA)
$2B